发明名称 |
Rasagiline for parkinson's disease modification |
摘要 |
A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.
|
申请公布号 |
US2009312436(A1) |
申请公布日期 |
2009.12.17 |
申请号 |
US20090456166 |
申请日期 |
2009.06.12 |
申请人 |
LEVY RUTH;EYAL ELI;GOREN TAMAR;OREN SHEILA;SAYAG NAIM;WEISS YONATAN;BEN-AMI MIRI |
发明人 |
LEVY RUTH;EYAL ELI;GOREN TAMAR;OREN SHEILA;SAYAG NAIM;WEISS YONATAN;BEN-AMI MIRI |
分类号 |
A61K31/135;A61P25/28 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|